Avicanna Inc., a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, announced that the Company has satisfied all regulatory requirements to successfully register the first three products of its premium CBD-based derma-cosmetic product line, Pura Earth™, on the European Commission’s Cosmetic Product Notification Portal (the “CPNP”). The first group of products registered with the CPNP are Pura Earth’s Anti-Aging Cream, Intensive Moisturizing Cream and Clear Skin Gel products.
In addition to the clinical studies conducted on two of the registered products, the Company has provided the CPNP with long-term stability studies on its initial SKUs along with primary skin irritation evaluations for the entire portfolio in order to certify the safety and stability of the Pura Earth formulations. Two additional SKUs will be registered in Q3 followed by the rest of the portfolio in Q4.
Aras Azadian, CEO of Avicanna said: “We take pride in our scientific and evidence-based approach within all of our product categories including our consumer products and have taken the appropriate steps to ensure our products would meet the European Union quality and safety standards prior to commercialization. We are thrilled to be getting closer to launch, what we believe to be, the most advanced and the only clinically backed CBD derma-cosmetic line into the European marketplace with potential for incredible success.”
Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.